According to Phys.org, researchers from Sylvester Comprehensive Cancer Center, University of Miami, Moffitt Cancer Center and Cellular Nanomed have developed magnetoelectric nanoparticles that can wirelessly locate and destroy pancreatic tumors. In a study published November 3, 2025, in Advanced Science, a single intravenous dose of these particles activated by MRI magnetic fields shrank tumors to one-third their original size and completely eliminated them in one-third of preclinical models. The treatment more than doubled survival time without damaging healthy organs. Unlike chemotherapy or surgery, this approach uses no drugs, heat, or invasive procedures. The technology represents a potential breakthrough for pancreatic ductal adenocarcinoma, which has a five-year survival rate below 10% and is projected to become the second leading cause of cancer deaths by 2030.
Sponsored content — provided for informational and promotional purposes.
How this wireless cancer therapy actually works
Here’s the thing that makes this different from other electric field treatments – it’s completely wireless and drug-free. Basically, they inject these tiny magnetoelectric nanoparticles into the bloodstream, use a small magnet to guide them to the tumor, then zap them with the magnetic field inside a standard MRI machine. When the particles get activated, they generate these incredibly localized electric fields that disrupt cancer cell membranes and trigger natural cell death.
What’s clever about this approach is how it distinguishes between healthy and cancerous cells. The electric fields apparently target cells based on their molecular properties, so only the malignant ones undergo apoptosis. And because human tissue conducts electricity, previous attempts to manipulate electric fields inside the body have been nearly impossible to control precisely. These nanoparticles solve that by creating hyper-localized fields right where they’re needed.
Why pancreatic cancer needs better options
Pancreatic cancer is basically the nightmare scenario in oncology. We’re talking about a disease where the five-year survival rate is still in the single digits, and it’s projected to become the second leading cause of cancer deaths in the US by 2030. Traditional treatments like surgery, radiation, and chemotherapy often cause massive collateral damage to healthy tissue.
Even newer approaches like immunotherapy have shown limited success against pancreatic tumors. So when researchers talk about doubling survival time and making tumors disappear completely in one-third of models without damaging healthy organs? That’s the kind of breakthrough this field desperately needs.
The road to human trials
Now, let’s be realistic – this is still preclinical research. The team believes it paves the way for future clinical trials, but we’re probably years away from seeing this in human patients. The concept actually dates back to 2011 when co-senior author Sakhrat Khizroev first proposed using MENPs to wirelessly control electric fields.
What’s interesting is that this represents what they call a “theranostic” approach – meaning it combines therapy and diagnostics in one package. The MRI scans not only activate the particles but also confirm the treatment is working by showing reduced tumor size and producing clear imaging signals. If this technology does translate successfully to humans, it could potentially be applied to other difficult-to-treat cancers beyond pancreatic.
The full study is available in Advanced Science for those who want to dive into the technical details. But the big picture is clear – we’re seeing the emergence of a completely new way to think about cancer treatment that’s wireless, precise, and potentially much safer than current options.
